Related references
Note: Only part of the references are listed.Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing
Mario Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2015)
Identification of black market products and potential doping agents in Germany 2010-2013
Oliver Krug et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls
Mario Thevis et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Annual banned-substance review: analytical approaches in human sports drug testing
Mario Thevis et al.
DRUG TESTING AND ANALYSIS (2013)
The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men
Shehzad Basaria et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential
Simone Esposito et al.
DRUG TESTING AND ANALYSIS (2012)
Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products
Simone Esposito et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2012)
Trafficking of drug candidates relevant for sports drug testing: Detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet
Mario Thevis et al.
DRUG TESTING AND ANALYSIS (2011)
SARM-S4 and metabolites detection in sports drug testing: A case report
Elia Grata et al.
FORENSIC SCIENCE INTERNATIONAL (2011)
Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls
Mario Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2011)
Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens
Mario Thevis et al.
DRUG TESTING AND ANALYSIS (2010)
Confiscated Black Market Products and Nutritional Supplements with Non-Approved Ingredients Analyzed in the Cologne Doping Control Laboratory 2009
Maxie Kohler et al.
DRUG TESTING AND ANALYSIS (2010)
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation
John Henninge et al.
DRUG TESTING AND ANALYSIS (2010)
Detection of His-tagged Long-R3-IGF-I in a black market product
Maxie Kohler et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes
Mario Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2010)
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis
Mario Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities Applied modifications in the steroidal structure
A. G. Fragkaki et al.
STEROIDS (2009)
Mass spectrometry of selective androgen receptor modulators
Mario Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2008)
Aryl-propionamide-derived selective androgen receptor modulators: Liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes
Tiia Kuuranne et al.
DRUG METABOLISM AND DISPOSITION (2008)
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)
Wenqing Gao et al.
DRUG DISCOVERY TODAY (2007)
Characterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparations
WQ Gao et al.
DRUG METABOLISM AND DISPOSITION (2006)
Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes
M Thevis et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Discovery and therapeutic promise of selective androgen receptor modulators
JY Chen et al.
MOLECULAR INTERVENTIONS (2005)
NADPH-dependent metabolism of 17β-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms
BT Zhu et al.
STEROIDS (2005)